-0.130 (-1.55%)
Range 8.050 - 8.430   (4.72%)
Open 8.370
Previous Close 8.380
Buy Price 7.560
Buy Volume 8
Sell Price 8.680
Sell Volume 11
Volume 854,009
Value -
Measurement Type Value
EPS (USD) -0.338
Trailing EPS (USD) -0.298
NAV (USD) -0.902
Cash In Hand (USD) 0.074
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV -0.809
Price / Cash In Hand 9.905
Issued & Paid-up Shares 21,758,000
Treasury Shares 4,015,000
Market Cap (M) 15.883
Par Value (USD) n.a.
Beta - 75 Days -0.144
R-Squared - 75 Days(%) -
Beta - 500 Days 0.939
R-Squared - 500 Days(%) 1.54
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 17 Apr 2021 04:00.
Data powered by
View All Events


Stereotaxis, Inc designs, manufactures and markets robotic systems and instruments for use primarily by electrophysiologists for the treatment of abnormal heart rhythms known as cardiac arrhythmias. The Company offers its Epoch Solution, an advanced remote robotic navigation system for use in a hospital�s interventional surgical suite, or interventional lab. The Epoch Solution is comprised of the Niobe ES Robotic Magnetic Navigation System (Niobe ES system), Odyssey Information Management Solution (Odyssey Solution), and the Vdrive Robotic Navigation System (Vdrive system). Its Niobe ES system is the latest generation of the Niobe Robotic Magnetic Navigation System (Niobe system), which allows physicians to more effectively navigate catheters, guidewires and other delivery devices, both its own and those the Company is co-developing through strategic alliances, through the blood vessels and chambers of the heart to treatment sites in order to effect treatment.

Loading Chart...